Global Non-Invasive Cancer Diagnostics Market Insights and Forecast to 2031

Report ID: 1197217 | Published Date: Jan 2025 | No. of Page: 107 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Non-Invasive Cancer Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 CTCs
        1.2.3 CTNAS
        1.2.4 Exosomes
    1.3 Market by Application
        1.3.1 Global Non-Invasive Cancer Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Blood
        1.3.3 Urine
        1.3.4 Saliva
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Non-Invasive Cancer Diagnostics Market Perspective (2017-2028)
    2.2 Non-Invasive Cancer Diagnostics Growth Trends by Region
        2.2.1 Non-Invasive Cancer Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Non-Invasive Cancer Diagnostics Historic Market Size by Region (2017-2022)
        2.2.3 Non-Invasive Cancer Diagnostics Forecasted Market Size by Region (2023-2028)
    2.3 Non-Invasive Cancer Diagnostics Market Dynamics
        2.3.1 Non-Invasive Cancer Diagnostics Industry Trends
        2.3.2 Non-Invasive Cancer Diagnostics Market Drivers
        2.3.3 Non-Invasive Cancer Diagnostics Market Challenges
        2.3.4 Non-Invasive Cancer Diagnostics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Non-Invasive Cancer Diagnostics Players by Revenue
        3.1.1 Global Top Non-Invasive Cancer Diagnostics Players by Revenue (2017-2022)
        3.1.2 Global Non-Invasive Cancer Diagnostics Revenue Market Share by Players (2017-2022)
    3.2 Global Non-Invasive Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Non-Invasive Cancer Diagnostics Revenue
    3.4 Global Non-Invasive Cancer Diagnostics Market Concentration Ratio
        3.4.1 Global Non-Invasive Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Non-Invasive Cancer Diagnostics Revenue in 2021
    3.5 Non-Invasive Cancer Diagnostics Key Players Head office and Area Served
    3.6 Key Players Non-Invasive Cancer Diagnostics Product Solution and Service
    3.7 Date of Enter into Non-Invasive Cancer Diagnostics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Non-Invasive Cancer Diagnostics Breakdown Data by Type
    4.1 Global Non-Invasive Cancer Diagnostics Historic Market Size by Type (2017-2022)
    4.2 Global Non-Invasive Cancer Diagnostics Forecasted Market Size by Type (2023-2028)
5 Non-Invasive Cancer Diagnostics Breakdown Data by Application
    5.1 Global Non-Invasive Cancer Diagnostics Historic Market Size by Application (2017-2022)
    5.2 Global Non-Invasive Cancer Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Non-Invasive Cancer Diagnostics Market Size (2017-2028)
    6.2 North America Non-Invasive Cancer Diagnostics Market Size by Type
        6.2.1 North America Non-Invasive Cancer Diagnostics Market Size by Type (2017-2022)
        6.2.2 North America Non-Invasive Cancer Diagnostics Market Size by Type (2023-2028)
        6.2.3 North America Non-Invasive Cancer Diagnostics Market Share by Type (2017-2028)
    6.3 North America Non-Invasive Cancer Diagnostics Market Size by Application
        6.3.1 North America Non-Invasive Cancer Diagnostics Market Size by Application (2017-2022)
        6.3.2 North America Non-Invasive Cancer Diagnostics Market Size by Application (2023-2028)
        6.3.3 North America Non-Invasive Cancer Diagnostics Market Share by Application (2017-2028)
    6.4 North America Non-Invasive Cancer Diagnostics Market Size by Country
        6.4.1 North America Non-Invasive Cancer Diagnostics Market Size by Country (2017-2022)
        6.4.2 North America Non-Invasive Cancer Diagnostics Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Non-Invasive Cancer Diagnostics Market Size (2017-2028)
    7.2 Europe Non-Invasive Cancer Diagnostics Market Size by Type
        7.2.1 Europe Non-Invasive Cancer Diagnostics Market Size by Type (2017-2022)
        7.2.2 Europe Non-Invasive Cancer Diagnostics Market Size by Type (2023-2028)
        7.2.3 Europe Non-Invasive Cancer Diagnostics Market Share by Type (2017-2028)
    7.3 Europe Non-Invasive Cancer Diagnostics Market Size by Application
        7.3.1 Europe Non-Invasive Cancer Diagnostics Market Size by Application (2017-2022)
        7.3.2 Europe Non-Invasive Cancer Diagnostics Market Size by Application (2023-2028)
        7.3.3 Europe Non-Invasive Cancer Diagnostics Market Share by Application (2017-2028)
    7.4 Europe Non-Invasive Cancer Diagnostics Market Size by Country
        7.4.1 Europe Non-Invasive Cancer Diagnostics Market Size by Country (2017-2022)
        7.4.2 Europe Non-Invasive Cancer Diagnostics Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Non-Invasive Cancer Diagnostics Market Size (2017-2028)
    8.2 Asia-Pacific Non-Invasive Cancer Diagnostics Market Size by Type
        8.2.1 Asia-Pacific Non-Invasive Cancer Diagnostics Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Non-Invasive Cancer Diagnostics Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Non-Invasive Cancer Diagnostics Market Share by Type (2017-2028)
    8.3 Asia-Pacific Non-Invasive Cancer Diagnostics Market Size by Application
        8.3.1 Asia-Pacific Non-Invasive Cancer Diagnostics Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Non-Invasive Cancer Diagnostics Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Non-Invasive Cancer Diagnostics Market Share by Application (2017-2028)
    8.4 Asia-Pacific Non-Invasive Cancer Diagnostics Market Size by Region
        8.4.1 Asia-Pacific Non-Invasive Cancer Diagnostics Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Non-Invasive Cancer Diagnostics Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Non-Invasive Cancer Diagnostics Market Size (2017-2028)
    9.2 Latin America Non-Invasive Cancer Diagnostics Market Size by Type
        9.2.1 Latin America Non-Invasive Cancer Diagnostics Market Size by Type (2017-2022)
        9.2.2 Latin America Non-Invasive Cancer Diagnostics Market Size by Type (2023-2028)
        9.2.3 Latin America Non-Invasive Cancer Diagnostics Market Share by Type (2017-2028)
    9.3 Latin America Non-Invasive Cancer Diagnostics Market Size by Application
        9.3.1 Latin America Non-Invasive Cancer Diagnostics Market Size by Application (2017-2022)
        9.3.2 Latin America Non-Invasive Cancer Diagnostics Market Size by Application (2023-2028)
        9.3.3 Latin America Non-Invasive Cancer Diagnostics Market Share by Application (2017-2028)
    9.4 Latin America Non-Invasive Cancer Diagnostics Market Size by Country
        9.4.1 Latin America Non-Invasive Cancer Diagnostics Market Size by Country (2017-2022)
        9.4.2 Latin America Non-Invasive Cancer Diagnostics Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Non-Invasive Cancer Diagnostics Market Size (2017-2028)
    10.2 Middle East & Africa Non-Invasive Cancer Diagnostics Market Size by Type
        10.2.1 Middle East & Africa Non-Invasive Cancer Diagnostics Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Non-Invasive Cancer Diagnostics Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Non-Invasive Cancer Diagnostics Market Share by Type (2017-2028)
    10.3 Middle East & Africa Non-Invasive Cancer Diagnostics Market Size by Application
        10.3.1 Middle East & Africa Non-Invasive Cancer Diagnostics Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Non-Invasive Cancer Diagnostics Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Non-Invasive Cancer Diagnostics Market Share by Application (2017-2028)
    10.4 Middle East & Africa Non-Invasive Cancer Diagnostics Market Size by Country
        10.4.1 Middle East & Africa Non-Invasive Cancer Diagnostics Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Non-Invasive Cancer Diagnostics Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Gen-Probe Inc
        11.1.1 Gen-Probe Inc Company Details
        11.1.2 Gen-Probe Inc Business Overview
        11.1.3 Gen-Probe Inc Non-Invasive Cancer Diagnostics Introduction
        11.1.4 Gen-Probe Inc Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022)
        11.1.5 Gen-Probe Inc Recent Developments
    11.2 Digene Corporation
        11.2.1 Digene Corporation Company Details
        11.2.2 Digene Corporation Business Overview
        11.2.3 Digene Corporation Non-Invasive Cancer Diagnostics Introduction
        11.2.4 Digene Corporation Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022)
        11.2.5 Digene Corporation Recent Developments
    11.3 Quest Diagnostics Inc
        11.3.1 Quest Diagnostics Inc Company Details
        11.3.2 Quest Diagnostics Inc Business Overview
        11.3.3 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Introduction
        11.3.4 Quest Diagnostics Inc Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022)
        11.3.5 Quest Diagnostics Inc Recent Developments
    11.4 Cancer, Genetics Inc
        11.4.1 Cancer, Genetics Inc Company Details
        11.4.2 Cancer, Genetics Inc Business Overview
        11.4.3 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Introduction
        11.4.4 Cancer, Genetics Inc Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022)
        11.4.5 Cancer, Genetics Inc Recent Developments
    11.5 BIOVIEW Inc
        11.5.1 BIOVIEW Inc Company Details
        11.5.2 BIOVIEW Inc Business Overview
        11.5.3 BIOVIEW Inc Non-Invasive Cancer Diagnostics Introduction
        11.5.4 BIOVIEW Inc Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022)
        11.5.5 BIOVIEW Inc Recent Developments
    11.6 AVIVA Biosciences Corporation
        11.6.1 AVIVA Biosciences Corporation Company Details
        11.6.2 AVIVA Biosciences Corporation Business Overview
        11.6.3 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Introduction
        11.6.4 AVIVA Biosciences Corporation Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022)
        11.6.5 AVIVA Biosciences Corporation Recent Developments
    11.7 Laboratory Corporation of America Holdings (LabCorp)
        11.7.1 Laboratory Corporation of America Holdings (LabCorp) Company Details
        11.7.2 Laboratory Corporation of America Holdings (LabCorp) Business Overview
        11.7.3 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Introduction
        11.7.4 Laboratory Corporation of America Holdings (LabCorp) Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022)
        11.7.5 Laboratory Corporation of America Holdings (LabCorp) Recent Developments
    11.8 A&G Pharmaceutical
        11.8.1 A&G Pharmaceutical Company Details
        11.8.2 A&G Pharmaceutical Business Overview
        11.8.3 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Introduction
        11.8.4 A&G Pharmaceutical Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022)
        11.8.5 A&G Pharmaceutical Recent Developments
    11.9 Affymetrix Inc
        11.9.1 Affymetrix Inc Company Details
        11.9.2 Affymetrix Inc Business Overview
        11.9.3 Affymetrix Inc Non-Invasive Cancer Diagnostics Introduction
        11.9.4 Affymetrix Inc Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022)
        11.9.5 Affymetrix Inc Recent Developments
    11.10 Precision Therapeutics
        11.10.1 Precision Therapeutics Company Details
        11.10.2 Precision Therapeutics Business Overview
        11.10.3 Precision Therapeutics Non-Invasive Cancer Diagnostics Introduction
        11.10.4 Precision Therapeutics Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022)
        11.10.5 Precision Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Non-Invasive Cancer Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of CTCs
    Table 3. Key Players of CTNAS
    Table 4. Key Players of Exosomes
    Table 5. Global Non-Invasive Cancer Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Non-Invasive Cancer Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Non-Invasive Cancer Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Non-Invasive Cancer Diagnostics Market Share by Region (2017-2022)
    Table 9. Global Non-Invasive Cancer Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Non-Invasive Cancer Diagnostics Market Share by Region (2023-2028)
    Table 11. Non-Invasive Cancer Diagnostics Market Trends
    Table 12. Non-Invasive Cancer Diagnostics Market Drivers
    Table 13. Non-Invasive Cancer Diagnostics Market Challenges
    Table 14. Non-Invasive Cancer Diagnostics Market Restraints
    Table 15. Global Non-Invasive Cancer Diagnostics Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Non-Invasive Cancer Diagnostics Revenue Share by Players (2017-2022)
    Table 17. Global Top Non-Invasive Cancer Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Cancer Diagnostics as of 2021)
    Table 18. Ranking of Global Top Non-Invasive Cancer Diagnostics Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Non-Invasive Cancer Diagnostics Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Non-Invasive Cancer Diagnostics Product Solution and Service
    Table 22. Date of Enter into Non-Invasive Cancer Diagnostics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Non-Invasive Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Non-Invasive Cancer Diagnostics Revenue Market Share by Type (2017-2022)
    Table 26. Global Non-Invasive Cancer Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Non-Invasive Cancer Diagnostics Revenue Market Share by Type (2023-2028)
    Table 28. Global Non-Invasive Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Non-Invasive Cancer Diagnostics Revenue Share by Application (2017-2022)
    Table 30. Global Non-Invasive Cancer Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Non-Invasive Cancer Diagnostics Revenue Share by Application (2023-2028)
    Table 32. North America Non-Invasive Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Non-Invasive Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Non-Invasive Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Non-Invasive Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Non-Invasive Cancer Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Non-Invasive Cancer Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Non-Invasive Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Non-Invasive Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Non-Invasive Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Non-Invasive Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Non-Invasive Cancer Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Non-Invasive Cancer Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Non-Invasive Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Non-Invasive Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Non-Invasive Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Non-Invasive Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Non-Invasive Cancer Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Non-Invasive Cancer Diagnostics Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Non-Invasive Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Non-Invasive Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Non-Invasive Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Non-Invasive Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Non-Invasive Cancer Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Non-Invasive Cancer Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Non-Invasive Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Non-Invasive Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Non-Invasive Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Non-Invasive Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Non-Invasive Cancer Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Non-Invasive Cancer Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Gen-Probe Inc Company Details
    Table 63. Gen-Probe Inc Business Overview
    Table 64. Gen-Probe Inc Non-Invasive Cancer Diagnostics Product
    Table 65. Gen-Probe Inc Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 66. Gen-Probe Inc Recent Developments
    Table 67. Digene Corporation Company Details
    Table 68. Digene Corporation Business Overview
    Table 69. Digene Corporation Non-Invasive Cancer Diagnostics Product
    Table 70. Digene Corporation Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 71. Digene Corporation Recent Developments
    Table 72. Quest Diagnostics Inc Company Details
    Table 73. Quest Diagnostics Inc Business Overview
    Table 74. Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Product
    Table 75. Quest Diagnostics Inc Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 76. Quest Diagnostics Inc Recent Developments
    Table 77. Cancer, Genetics Inc Company Details
    Table 78. Cancer, Genetics Inc Business Overview
    Table 79. Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Product
    Table 80. Cancer, Genetics Inc Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 81. Cancer, Genetics Inc Recent Developments
    Table 82. BIOVIEW Inc Company Details
    Table 83. BIOVIEW Inc Business Overview
    Table 84. BIOVIEW Inc Non-Invasive Cancer Diagnostics Product
    Table 85. BIOVIEW Inc Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 86. BIOVIEW Inc Recent Developments
    Table 87. AVIVA Biosciences Corporation Company Details
    Table 88. AVIVA Biosciences Corporation Business Overview
    Table 89. AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Product
    Table 90. AVIVA Biosciences Corporation Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 91. AVIVA Biosciences Corporation Recent Developments
    Table 92. Laboratory Corporation of America Holdings (LabCorp) Company Details
    Table 93. Laboratory Corporation of America Holdings (LabCorp) Business Overview
    Table 94. Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Product
    Table 95. Laboratory Corporation of America Holdings (LabCorp) Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 96. Laboratory Corporation of America Holdings (LabCorp) Recent Developments
    Table 97. A&G Pharmaceutical Company Details
    Table 98. A&G Pharmaceutical Business Overview
    Table 99. A&G Pharmaceutical Non-Invasive Cancer Diagnostics Product
    Table 100. A&G Pharmaceutical Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 101. A&G Pharmaceutical Recent Developments
    Table 102. Affymetrix Inc Company Details
    Table 103. Affymetrix Inc Business Overview
    Table 104. Affymetrix Inc Non-Invasive Cancer Diagnostics Product
    Table 105. Affymetrix Inc Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 106. Affymetrix Inc Recent Developments
    Table 107. Precision Therapeutics Company Details
    Table 108. Precision Therapeutics Business Overview
    Table 109. Precision Therapeutics Non-Invasive Cancer Diagnostics Product
    Table 110. Precision Therapeutics Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 111. Precision Therapeutics Recent Developments
    Table 112. Research Programs/Design for This Report
    Table 113. Key Data Information from Secondary Sources
    Table 114. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Non-Invasive Cancer Diagnostics Market Share by Type: 2021 VS 2028
    Figure 2. CTCs Features
    Figure 3. CTNAS Features
    Figure 4. Exosomes Features
    Figure 5. Global Non-Invasive Cancer Diagnostics Market Share by Application: 2021 VS 2028
    Figure 6. Blood Case Studies
    Figure 7. Urine Case Studies
    Figure 8. Saliva Case Studies
    Figure 9. Non-Invasive Cancer Diagnostics Report Years Considered
    Figure 10. Global Non-Invasive Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Non-Invasive Cancer Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Non-Invasive Cancer Diagnostics Market Share by Region: 2021 VS 2028
    Figure 13. Global Non-Invasive Cancer Diagnostics Market Share by Players in 2021
    Figure 14. Global Top Non-Invasive Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Cancer Diagnostics as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Non-Invasive Cancer Diagnostics Revenue in 2021
    Figure 16. North America Non-Invasive Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 17. North America Non-Invasive Cancer Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 18. North America Non-Invasive Cancer Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 19. North America Non-Invasive Cancer Diagnostics Market Size Share by Country (2017-2028)
    Figure 20. United States Non-Invasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Non-Invasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Non-Invasive Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Non-Invasive Cancer Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 24. Europe Non-Invasive Cancer Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 25. Europe Non-Invasive Cancer Diagnostics Market Size Share by Country (2017-2028)
    Figure 26. Germany Non-Invasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Non-Invasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Non-Invasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Non-Invasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Non-Invasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Non-Invasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Non-Invasive Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 33. Asia Pacific Non-Invasive Cancer Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 34. Asia Pacific Non-Invasive Cancer Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 35. Asia Pacific Non-Invasive Cancer Diagnostics Market Size Share by Region (2017-2028)
    Figure 36. China Non-Invasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan Non-Invasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea Non-Invasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia Non-Invasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India Non-Invasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia Non-Invasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Latin America Non-Invasive Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 43. Latin America Non-Invasive Cancer Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 44. Latin America Non-Invasive Cancer Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 45. Latin America Non-Invasive Cancer Diagnostics Market Size Share by Country (2017-2028)
    Figure 46. Mexico Non-Invasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Brazil Non-Invasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Non-Invasive Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 49. Middle East and Africa Non-Invasive Cancer Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 50. Middle East and Africa Non-Invasive Cancer Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 51. Middle East and Africa Non-Invasive Cancer Diagnostics Market Size Share by Country (2017-2028)
    Figure 52. Turkey Non-Invasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Non-Invasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. UAE Non-Invasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Gen-Probe Inc Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2017-2022)
    Figure 56. Digene Corporation Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2017-2022)
    Figure 57. Quest Diagnostics Inc Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2017-2022)
    Figure 58. Cancer, Genetics Inc Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2017-2022)
    Figure 59. BIOVIEW Inc Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2017-2022)
    Figure 60. AVIVA Biosciences Corporation Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2017-2022)
    Figure 61. Laboratory Corporation of America Holdings (LabCorp) Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2017-2022)
    Figure 62. A&G Pharmaceutical Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2017-2022)
    Figure 63. Affymetrix Inc Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2017-2022)
    Figure 64. Precision Therapeutics Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2017-2022)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Gen-Probe Inc
Digene Corporation
Quest Diagnostics Inc
Cancer, Genetics Inc
BIOVIEW Inc
AVIVA Biosciences Corporation
Laboratory Corporation of America Holdings (LabCorp)
A&G Pharmaceutical
Affymetrix Inc
Precision Therapeutics
Frequently Asked Questions
Non-Invasive Cancer Diagnostics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Non-Invasive Cancer Diagnostics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Non-Invasive Cancer Diagnostics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports